Reasons to Retain Penumbra Stock in Your Portfolio for Now [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
The company's robust product portfolio expansion is poised to drive growth in the upcoming quarters. Meanwhile, unfavorable foreign exchange and intense competition may pose operational risks for PEN. In the past year, shares of this Zacks Rank #2 (Buy) company have increased 19.8% against the industry's 18.4% decline and the S&P 500 composite's fell of 1.9%. The global healthcare provider company has a market capitalization of $10.15 billion. PEN beat on earnings in three of the trailing four quarters and missed on one occasion, the average surprise being 10.42%. Strong Portfolio Expansion : Penumbra is still in the early stages of its journey to bring the company's proprietary thrombectomy technologies to patients in the United States and abroad. In terms of product launch, the Element Vascular Access System was launched in January 2025. Penumbra also launched its Lightning Bolt 12 and Lightning Bolt 6x with TraX in 2025. These additions to Penumbra's CAVT platform aim to enha
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra (NYSE:PEN) was given a new $345.00 price target on by analysts at Robert W. Baird.MarketBeat
- Penumbra (NYSE:PEN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
- Penumbra (NYSE:PEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Penumbra (NYSE:PEN) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare ConferencePR Newswire
PEN
Earnings
- 11/5/25 - Beat
PEN
Sec Filings
- 12/15/25 - Form 4
- 12/9/25 - Form 4
- 12/3/25 - Form 4
- PEN's page on the SEC website